Stockreport

Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Cabaletta Bio, Inc.  (CABA) 
PDF PHILADELPHIA, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a late-stage clinical biotechnology company focused on developing and launching the [Read more]